GlaxoSmithKline Consumer Nigeria Plc (GSK) has announced that the company has now received formal Securities and Exchange Commission (SEC) approval of its proposed scheme of arrangement. GSK gets SEC’s approval to delist from NGX.Minority investors will receive a total cash distribution of N17.42 per share for every share held.In August, GlaxoSmithKline UK, a major player in the pharmaceutical industryannounced its exit from Nigeria after over 51 years of operations.Frederick Ichekwai, the company’s secretary, disclosed this information in a statement filed on the Nigerian Exchange Limited (NG…